OverviewChartNewsTraderScreen

BNP Paribas Knock-Out SNW 21.03.2.../  DE000PG8HSC0  /

Frankfurt Zert./BNP
11/15/2024  5:20:58 PM Chg.0.000 Bid5:37:52 PM Ask5:37:52 PM Underlying Strike price Expiration date Option type
9.700EUR 0.00% 9.400
Bid Size: 1,064		 10.000
Ask Size: 1,000		 SANOFI SA INHABER ... - EUR 3/21/2025 Call
TeleTrader 9:00 AM European markets dip as UK GDP growth misses forecasts
TeleTrader 10/25 Europe closes mixed amid earnings, data
TeleTrader 10/25 Europe lower in premarket as financial results pour in
TeleTrader 10/25 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 10/21 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 9/2 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 8/26 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 8/14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 8/13 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/12 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 8/12 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 8/8 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 8/6 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 8/5 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 8/2 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 8/1 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 8/1 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 7/31 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 7/25 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 7/25 Europe lower premarket as earnings pour in
TeleTrader 7/25 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 7/25 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 7/24 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...
GlobeNewswire 7/18 Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, Accord...
GlobeNewswire 7/17 Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transfor...